The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility.
复制标题
酒精、吸烟和药物参与筛查测试 (ASSIST)：开发、可靠性和可行性。
DOI：
10.1046/j.1360-0443.2002.00185.x
复制
发表时间：
2002
期刊：
影响因子：
--
通讯作者：
WHOASSISTWorkingGroup
中科院分区：
文献类型：
--
作者：
WHOASSISTWorkingGroup
酒精、吸烟和物质参与筛查测试（ASSIST）是由一个国际药物滥用研究小组为世界卫生组织（WHO）开发的，用于检测初级保健患者中精神活性物质的使用和相关问题。该研究在澳大利亚、巴西、爱尔兰、印度、以色列、巴勒斯坦领土、波多黎各、联合王国和津巴布韦的参与地点进行。百分之六十的样本被招募从酒精和药物滥用治疗设施，其余的是从一般的医疗环境和精神病facility.MethodsThe研究主要关注测试项目的可靠性，使用一个简单的测试，重测程序，以确定受试者是否会响应一致的相同的项目时，在两个不同的场合提出的采访格式。定性和定量的数据也收集到评估的可行性筛选项目和评级formation.PropantsA共236名志愿者参与者完成了测试和重测面试在9个合作网站。略超过一半的样本（53.6%）是男性。样本的平均年龄为34岁，他们已经完成，平均，10年的教育。ResultsThe平均重测信度系数（Kappas）范围从高的0.90（一致性报告“以往”使用的物质）到低的0.58（遗憾的是什么是做物质的影响下）。物质类别的平均kappas从镇静剂的0.61到阿片类的0.78不等。总体而言，可靠性在良好到优秀的范围内，以下项目在所有药物类别中表现出最高的Kappas：过去3个月内使用，专注于药物使用，他人表示的担忧，受药物使用相关问题困扰，静脉注射药物使用。在重测访谈结束时收集的定性数据表明，这些问题不难回答，与患者对健康访谈的期望一致。这些数据被用来指导选择一个较小的一组项目，可以作为更广泛的验证research.ConclusionThe ASSIST项目的基础是可靠的和可行的，使用作为国际筛选测试的一部分。应进一步评估筛选试验。
ABSTRACTAimsThe Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was developed for the World Health Organization (WHO) by an international group of substance abuse researchers to detect psychoactive substance use and related problems in primary care patients. This report describes the new instrument as well as a study of its reliability and feasibility.SettingThe study was conducted at participating sites in Australia, Brazil, Ireland, India, Israel, the Palestinian Territories, Puerto Rico, the United Kingdom and Zimbabwe. Sixty per cent of the sample was recruited from alcohol and drug abuse treatment facilities; the remainder was drawn from general medical settings and psychiatric facilities.MethodsThe study was concerned primarily with test item reliability, using a simple test–retest procedure to determine whether subjects would respond consistently to the same items when presented in an interview format on two different occasions. Qualitative and quantitative data were also collected to evaluate the feasibility of the screening items and rating format.ParticipantsA total of 236 volunteer participants completed test and retest interviews at nine collaborating sites. Slightly over half of the sample (53.6%) was male. The mean age of the sample was 34 years and they had completed, on average, 10 years of education.ResultsThe average test–retest reliability coefficients (kappas) ranged from a high of 0.90 (consistency of reporting ‘ever’ use of substance) to a low of 0.58 (regretted what was done under influence of substance). The average kappas for substance classes ranged from 0.61 for sedatives to 0.78 for opioids. In general, the reliabilities were in the range of good to excellent, with the following items demonstrating the highest kappas across all drug classes: use in the last 3 months, preoccupied with drug use, concern expressed by others, troubled by problems related to drug use, intravenous drug use. Qualitative data collected at the end of the retest interview suggested that the questions were not difficult to answer and were consistent with patients’ expectations for a health interview. The data were used to guide the selection of a smaller set of items that can serve as the basis for more extensive validation research.ConclusionThe ASSIST items are reliable and feasible to use as part of an international screening test. Further evaluation of the screening test should be conducted.
通过 MMPI 区分男性酒精门诊患者与非酒精精神科门诊患者。
影响因子：
--
作者：
C. Macandrew
通讯作者：
C. Macandrew